Collapse Skip to main content

At MedEngine, we are a team of over 40 pharmaceutical professionals based in Helsinki, Copenhagen, and Stockholm. We are actively engaged in a variety of market access and Nordic real-world data projects, with a specialization in rare disease access.

Our work leverages Nordic data to develop innovative payer solutions. Additionally, this data has versatile applications, including real-world evidence (RWE) studies, post-authorization safety studies (PASS), machine learning-based algorithm development, and the development of virtual control arms for clinical trials.

We are also well-equipped to design and execute data-driven activities, ranging from Market Access landscape analysis to digital stakeholder engagement. We work with Nordic, European, and global teams of our pharmaceutical customers.

Access of Rare Disease Treatments in the Nordics

If you would like to discuss more or book a meeting during the ISPOR Europe 2023 congress in Copenhagen 12 – 15 November, please contact us below!

Tero Ylisaukko-oja

CEO, Founder

+358 40 9012 975

Saku Torvinen

Director, Market Access

+358 40 551 1119

Send us a message

First name:
Your First Name
Field is required!
Field is required!
Last name:
Your Last Name
Field is required!
Field is required!
Your Email Address
Field is required!
Field is required!
Your Message
Field is required!
Field is required!
Helsinki office

Eteläranta 14
00130 Helsinki

Copenhagen office

Klosterstræde 23
1157 Copenhagen

Stockholm office

Östermalmstorg 1
114 42 Stockholm